NCT02070705 2025-07-31
DCE MRI in Patients With Pancreatic Cancer
OHSU Knight Cancer Institute
Phase NA Terminated
Clinical Trials
7 trialsNCT02857218 2021-09-16
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Stage IIB-IIIC Esophageal Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Withdrawn
NCT03280277 2021-09-10
Ferumoxytol-Enhanced MRI in Imaging Lymph Nodes in Patients With Locally Advanced Rectal Cancer
OHSU Knight Cancer Institute
Phase EARLY_PHASE1 Terminated
NCT01770353 2019-11-27
MM-398 (Nanoliposomal Irinotecan, Nal-IRI) to Determine Tumor Drug Levels and to Evaluate the Feasibility of Ferumoxytol Magnetic Resonance Imaging to Measure Tumor Associated Macrophages and to Predict Patient Response to Treatment
Ipsen
Phase 1 Completed
NCT02253602 2019-01-16
IMPROVE
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)
Phase NA Completed
NCT01983371 2016-05-20
Diagnostic Accuracy of Ferumoxytol-Enhanced MRI for Detecting Lymph Node Metastases in Colorectal Cancer
University of Vermont
Phase NA Withdrawn
NCT02689401 2016-05-13
MRI Iron Oxide Imaging for Lymph Node Staging in Esophageal Cancer
Dana-Farber Cancer Institute
Phase 1 Withdrawn